Controlled ovarian hyperstimulation in women with polycystic ovarian syndrome with or without intrauterine insemination

Gynecol Endocrinol. 2012 Jul;28(7):502-4. doi: 10.3109/09513590.2011.634938. Epub 2011 Nov 28.

Abstract

Objective: To evaluate the value of intrauterine insemination (IUI) in controlled ovarian hyperstimulation (COH) among couples with polycystic ovary syndrome (PCOS) and normal semen analysis.

Design: Retrospective cohort study.

Setting: University teaching center.

Patients: PCOS couples with normal semen analysis that underwent COH with IUI or timed intercourse (TIC).

Intervention: COH with clomiphene citrate, letrozole or gonadotropins with or without IUI.

Main outcome measures: Clinical pregnancy rates.

Results: Of a total 265 cycles, 151 cycles were with IUI and 114 others with TIC. No significant difference was found in the overall pregnancy rates between the TIC group (17.5%) and the IUI group (16.6%). Analysis of pregnancy rates according to the type of COH treatments did not demonstrate the advantages of IUI over TIC.

Conclusion: Compared to timed intercourse, IUI does not increase the pregnancy rate in couples with PCOS and normal semen analysis treated with COH.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aromatase Inhibitors / adverse effects
  • Aromatase Inhibitors / therapeutic use
  • Clomiphene / adverse effects
  • Clomiphene / therapeutic use
  • Cohort Studies
  • Female
  • Fertility Agents, Female / adverse effects
  • Fertility Agents, Female / therapeutic use*
  • Gonadotropins / adverse effects
  • Gonadotropins / therapeutic use
  • Humans
  • Infertility, Female / therapy*
  • Insemination, Artificial* / adverse effects
  • Letrozole
  • Nitriles / adverse effects
  • Nitriles / therapeutic use
  • Ovarian Hyperstimulation Syndrome / prevention & control
  • Ovulation Induction* / adverse effects
  • Ovulation Induction* / methods
  • Polycystic Ovary Syndrome / physiopathology*
  • Pregnancy
  • Pregnancy Rate
  • Quebec
  • Retrospective Studies
  • Selective Estrogen Receptor Modulators / adverse effects
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Sexual Behavior
  • Triazoles / adverse effects
  • Triazoles / therapeutic use

Substances

  • Aromatase Inhibitors
  • Fertility Agents, Female
  • Gonadotropins
  • Nitriles
  • Selective Estrogen Receptor Modulators
  • Triazoles
  • Clomiphene
  • Letrozole